2017
Group differences in pain interference, psychiatric disorders, and general medical conditions among Hispanics and whites in the U.S. general population
Barry DT, Glenn CP, Hoff RA, Potenza MN. Group differences in pain interference, psychiatric disorders, and general medical conditions among Hispanics and whites in the U.S. general population. Psychiatry Research 2017, 258: 337-343. PMID: 28886905, PMCID: PMC5681386, DOI: 10.1016/j.psychres.2017.08.049.Peer-Reviewed Original ResearchConceptsGeneral medical conditionsSevere pain interferenceModerate pain interferencePain interferenceMedical conditionsPsychiatric disordersCross-sectional retrospective studyNon-Hispanic white adultsLower pain interferenceGroup differencesSpecific psychiatric disordersU.S. general populationNational Epidemiologic SurveyHispanic respondentsEthnic health disparitiesWhite respondentsRetrospective studyMood disordersGeneral populationEpidemiologic SurveyWhite adultsHealth disparitiesDisordersHeart conditionsFurther studies
2013
Pain interference and incident mood, anxiety, and substance-use disorders: Findings from a representative sample of men and women in the general population
Barry DT, Pilver CE, Hoff RA, Potenza MN. Pain interference and incident mood, anxiety, and substance-use disorders: Findings from a representative sample of men and women in the general population. Journal Of Psychiatric Research 2013, 47: 1658-1664. PMID: 23992771, PMCID: PMC3835154, DOI: 10.1016/j.jpsychires.2013.08.004.Peer-Reviewed Original ResearchConceptsSevere pain interferencePain interferenceSubstance use disordersIncident moodNew onsetPsychiatric disordersModerate pain interferenceComorbid psychiatric disordersMajor depressive disorderLogistic regression analysisNational Epidemiologic SurveyBinomial logistic regression analysisChi-square testSubstance use problemsWave 1Depressive disorderMood disordersGeneral populationNicotine dependenceAlcohol abuseEpidemiologic SurveyRelated conditionsDisordersLongitudinal relationshipRegression analysis
2012
Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment
Savant JD, Barry DT, Cutter CJ, Joy MT, Dinh A, Schottenfeld RS, Fiellin DA. Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment. Drug And Alcohol Dependence 2012, 127: 243-247. PMID: 22771144, PMCID: PMC3525769, DOI: 10.1016/j.drugalcdep.2012.06.020.Peer-Reviewed Original ResearchConceptsBuprenorphine/naloxone treatmentNon-opioid substancesNaloxone treatmentPrevalence of moodPsychiatric comorbidityDSM-IV Axis I DisordersMinority of patientsMethadone maintenance treatmentStructured Clinical InterviewAxis I DisordersPrevalent mood disorderCross-sectional surveyCurrent dysthymiaConsecutive patientsMaintenance treatmentMajor depressionTreatment outcomesI disordersMood disordersPast diagnosisPatientsClinical InterviewSectional surveyComorbiditiesPrevalence